Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
Cross
J
J
University of Massachusetts Medical Center, USA.
Wedekind
C A
CA
D000081:Acetamides / Q000008:administration & dosage / Q000494:pharmacology*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology*; D017277:Drug Approval; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011714:Pyrans; D012680:Sensitivity and Specificity; D012794:Sialic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D014481:United States; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir